Optimise-HFpEF 2C - Transitions of care and Carers' Needs
Research type
Research Study
Full title
Transitions of care for patients with Heart Failure with Preserved Ejection Fraction (HFpEF) and Assessment of their Carers' needs and support required.
IRAS ID
249456
Contact name
Christi Deaton
Contact email
Sponsor organisation
Cambridge University Hospitals NHS FT and University of Cambridge
Clinicaltrials.gov Identifier
NCT03617848, ClinicalTrials.gov Identifier
Duration of Study in the UK
1 years, 0 months, 31 days
Research summary
Heart failure (HF) is a condition in which the heart does not work well to pump blood around the body. About half of all people with HF have a type in which the heart is very stiff called heart failure with preserved ejection fraction or HFpEF. The Optimise-HFpEF research programme includes talking to patients and providers about HFpEF, a cohort study that will identify and follow a group of patients with this type of HF for a year to better understand their HF, and exploring patients’ thoughts about hospitalisation and care between hospital and home, and its impact for both patients and their carers. To explore hospitalisation and the needs of informal carers (usually a family member) two smaller sub-studies are outlined. In sub-study 1 we will interview patients and carers about what they think led to being admitted, and their experience in hospital and after discharge. In sub-study 2 we will add to the hospitalisation interviews by interviewing additional carers of patients with HFpEF to ask about their needs and the type of support that they would like to have. We will also explore their views on a tool that helps carers assess support needs.
Interviews with patients and carers will be confidential, held in a place of the participant’s choosing, audio-recorded and then typed out.
This information will help us to plan better care and develop a programme of management for patients with HFpEF involving primary care and specialist services. The final agreed optimised management programme will be tested in future studies to see whether it improves patients’ care and health outcomes.REC name
North West - Preston Research Ethics Committee
REC reference
18/NW/0823
Date of REC Opinion
18 Dec 2018
REC opinion
Further Information Favourable Opinion